Rethinking pediatric clinical trials: guidelines from pediatric experts
In this last episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
How is the Kayentis Clin’form solution perceived by site staff users?
The survey, conducted in November 2022, involved 239 site respondents from Europe (47%), Americas (27%), Asia (20%), and the Middle East & Africa (6%). These respondents held various roles and conducted research across multiple therapeutic areas. The survey was co-developed with a group of worldwide site experts.
These positive findings reflect the user-friendly nature and high satisfaction rates of the Kayentis Clin’form solution among site staff users.
Learn more:
In this last episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
In this third episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
Integrating PROs into studies on MASH, also known as NASH, is crucial. MASH is a debilitating
Asthma clinical trials present several specificities, such as the use of disease-specific health-related quality of
NonAlcoholic SteatoHepatitis (NASH), now called Metabolic Dysfunction-Associated SteatoHepatitis (MASH), affects almost 115 million adults globally
In this second episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
Last update : 15 June 2023